YETI Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data YETI Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	819	639	779	914	1,092	1,411	1,595	1,659	1,830	1,868
Cost of revenue	405	345	396	438	463	595	832	716	767	796
Gross profit	414	295	383	475	629	816	763	943	1,063	1,073
Research and development	29.5	8.8	10.8	20.5	11.2	13.7	15.4	15.5	21.1	25.2
Selling, general and administrative	326	231	281	386	415	541	637	718	818	859
Operating income	88.2	64	102	89.8	214	275	126	225	245	214
Interest expense	21.7	32.6	31.3	21.8	9.16	3.34	4.47	0.94
Other non-operating income	-1.24	0.7	-1.26	-0.73	0.12	-3.19	-5.72	1.43	-13.2	7.17
Pre-tax income	65.3	32.1	69.6	67.3	205	268	116	226	233	220
Income tax	16.5	16.7	11.9	16.8	49.4	55.8	26.5	56.1	57.2	54.9
Net income to minority interests	0.81
Net income	48	15.4	57.8	50.4	156	213	89.7	170	176	165
EBITDA	99.9	84.7	127	119	245	307	166	272	294	268
EPS, basic	0.59	0.19	0.71	0.59	1.79	2.43	1.04	1.96	2.07	2.05
EPS, diluted	0.58	0.19	0.69	0.58	1.77	2.40	1.03	1.94	2.05	2.03
Shares, basic (weighted)	81.1	81.5	81.8	85.1	87	87.4	86.5	86.7	84.9	80.6
Shares, diluted (weighted)	82.8	83	83.5	86.3	87.8	88.7	87.2	87.4	85.8	81.6

Balance sheet

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	21.3	53.7	80.1	72.5	253	312	235	439	359	188
Receivables		67.2	59.3	82.7	65.4	110	79.4	95.8	120	141
Inventory		175	145	186	140	319	371	337	310	291
Other current assets		7.13	12.2	19.6	17.7	29.6	33.3	42.5	37.7	9.99
Total current assets		303	297	361	476	770	719	914	827	660
Property, plant and equipment		73.8	74.1	82.6	78.1	119	125	131	126	142
Lease right-of-use assets				37.8	34.1	55	55.4	77.6	78.3	132
Goodwill		54.3	54.3	54.3	54.3	54.3	54.3	54.3	72.6	72.3
Intangible assets		74.3	80	90.9	92.1	95.3	99.4	118	172	220
Other non-current assets					2.03	2.58	24.1	2.6	10.2	9.36
Total assets		516	514	630	737	1,096	1,077	1,297	1,286	1,235
Accounts payable		40.3	68.7	83.8	124	191	141	190	158	140
Accrued liabilities		6.36	15.6	18.1	25.8	30.8	4.85	23.1	28.6	22.7
Deferred revenue			9.46	4.5	11.1	20.8	7.7	22.4	10.5	9.54
Short-term debt		47.1	43.6	15	22.5	22.5	22.5	4.22	4.22	4.22
Total current liabilities		152	187	170	288	404	409	398	380	334
Long-term debt		429	284	282	111	95.7	71.7	78.6	72.8	68.3
Lease liabilities				42.2	36.5	55.9	55.6	76.2	73.6	140
Other non-current liabilities		12.1	13.5	13.3	13.3	23.1	13.9	20.4	20.1	42.6
Total liabilities		593	485	508	449	579	550	574	546	585
Total debt		485	333	300	135	113	90	82.3	78	73.8
Paid-in capital		219	268	311	322	338	357	386	406	472
Retained earnings		-296	-240	-190	-33.7	179	269	438	614	780
Treasury stock						0	-100	-100	-282	-602
Other comprehensive income		0.04	-0.09	0	-0.39	0.35	-0.42	-2.06	0.76	0.36
Shareholders' equity	-95.1	-76.2	29	122	288	518	526	724	740	650
Total equity	-95.1	-76.2	29	122	288	518	526	724	740	650
Total liabilities and equity		516	514	630	737	1,096	1,077	1,297	1,286	1,235
Shares outstanding		81.5	84.2	86.8	87.1	87.7	86.4	86.9	82.9	75

Cash flow statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	48.8	15.4	57.8	50.4	156	213	89.7	170	176	165
Depreciation and amortization	11.7	20.8	24.8	29	30.5	32.1	39.8	46.4	48.1	54.2
Stock-based compensation	118	13.4	13.2	52.3	9.01	15.5	17.8	29.8	40.7	47.7
Deferred income tax	-20.9	8.79	2.1	14.2	-3.93	5.1	-32.6	25.3	-11.2	27.7
Change in receivables	8.83	-29.9	7.68	-19.9	16.4	-44.7	30.4	-15.7	-23.7	-18.2
Change in inventory	-151	71	29.6	-40.5	46.1	-180	-91.6	33.7	39.8	23.9
Change in payables	7.89	28	43.7	6.61	89.1	113	-86.2	-15.1	-47	-27.7
Cash from operations	28.9	148	176	86.9	366	147	101	286	261	255
Capital expenditures	-35.6	-42.2	-20.9	-32.1	-15.6	-56.1	-45.9	-50.7	-41.8	-42.7
Acquisitions		-2.87	0	0			0	0	-36.2	0
Cash from investing	-55.9	-38.7	-31.7	-48.7	-22.9	-65.8	-56.9	-72.8	-131	-102
Debt issued	550	0	0	66.2	0	0
Debt repaid	-84.5	-45.6	-152	-34.9	-165	-22.5	-22.5	-7.73	-4.22	-4.22
Stock issued	0.71	0	38.1	0	0
Share buybacks		0	-1.97	0	0	0	-100	0	-200	-298
Dividends paid	-454	-2.81	-2.52	-0.64	0	0
Cash from financing	8.01	-72.2	-118	-45.7	-163	-23	-123	-13.6	-209	-321
Exchange rate effect		-0	0.05	-0.05	0.48	1.16	1.2	4.7	-0.89	-1.96
Net change in cash	-19	32.4	26.4	-7.54	181	58.9	-77.4	204	-80.2	-170
Free cash flow	-6.68	106	155	54.8	351	90.4	55	235	220	212
Interest paid	19.6	29.9	28.5	19.4	8.36	2.37	2.96	6.69	5.81	4.75
Income taxes paid	25.3	20.6	16.3	3.52	36.3	58.8	58.8	14.1	65.2	48

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $42.28 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	59.2%	Gross profit / revenue.
Operating margin	12.2%	Operating income / revenue.
Pre-tax margin	12.2%	Pre-tax income / revenue.
Net margin	9.2%	Net income / revenue.
Effective tax rate	24.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	29.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	13.7%	Net income / average total assets.
Return on invested capital (ROIC)	27.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	47.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	2.3%	Stock-based compensation (from the cash flow statement) / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	2.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	11.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	0.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	12.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-13.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	19.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-0.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-8.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	17.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	1.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-5.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	22.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	1.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-1.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	25.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	2.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-2.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	36.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-7.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-3.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	56.8%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-9.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-12.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	17.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-3.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.75x	Current assets / current liabilities.
Quick ratio	0.57x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.15x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.16x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	7.4%	Total debt / total assets.
Liabilities / assets	53.2%	Total liabilities / total assets.
Net debt	$36.6M	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$307.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	22.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$311.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.49x	Revenue / average total assets.
Fixed asset turnover	12.9x	Revenue / average property, plant and equipment.
Inventory turnover	2.20x	Cost of revenue / average inventory.
Days inventory	166 days	365 x average inventory / cost of revenue.
Receivables turnover	11.1x	Revenue / average receivables.
Days sales outstanding	33 days	365 x average receivables / revenue.
Days payables	97 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	102 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.36	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$25.54	Revenue / diluted weighted shares.
Book value per share	$8.35	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$4.26	Tangible book value / shares outstanding.
Cash per share	$0.82	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$3.09B	Share price x shares outstanding.
Enterprise value	$3.12B	Market cap + total debt - cash - short-term investments.
P/E	17.3x	Market cap / net income. Only when net income is positive.
P/S	1.59x	Market cap / revenue.
P/B	5.06x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	9.92x	Market cap / tangible book value, when positive.
EV/Sales	1.61x	Enterprise value / revenue.
EV/EBIT	13.2x	Enterprise value / operating income, when both are positive.
Earnings yield	5.8%	Net income / market cap (the inverse of P/E).
PEG	0.68x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was YETI Holdings, Inc.'s revenue in fiscal 2025?

YETI Holdings, Inc. reported revenue of $1.87B for fiscal 2025, 2.1% higher than the year before.

Was YETI Holdings, Inc. profitable in fiscal 2025?

Yes. Net income was $165.4M, a net margin of 8.9%.

How much free cash flow did YETI Holdings, Inc. generate in fiscal 2025?

Cash from operations of $254.7M minus capital expenditures of $42.7M left free cash flow of $212.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to YETI Holdings, Inc.